<p class="p1"><span class="s1">The Association for Psychological Science (APS) Observer has released the news story below titled <i>Congress Stops NIH from Implementing New Clinical Trials Policy</i>:</span></p> <p class="p1"><span class="s1">The US Congress has directed the National Institutes of Health (NIH) to “delay enforcement” of a new policy that would reclassify basic research involving humans as “clinical trials.” Lawmakers concluded that the research community was not adequately consulted about this change and that the policy could have “long-term unintended consequences,” including unnecessary regulations and the inappropriate inclusion of non-clinical trials in NIH’s <a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__clinicaltrials.gov_&d=DwMFaQ&c=l45AxH-kUV29SRQusp9vYR0n1GycN4_2jInuKy6zbqQ&r=GQ_YxziWQ42MsCw7nIWv_-H78YCdZwwchsCmxOn3OrI&m=gwKRNo_FOLRAF4jhd2HkRcnbdwZiTEssf2-5AMuIrYI&s=6j-jPmvpK96_yX8IC8jLnKnjZOSJAwfkfqdsW4y1MaA&e="><span class="s2">clinicaltrials.gov</span></a> database. The Association for Psychological Science (APS) has been a leading voice in opposing NIH’s redefinition of clinical trials, which would have brought basic behavioral and neuroscience research under the umbrella of clinical trials, and would have subjected those areas to unwarranted, costly, and time-consuming administrative requirements. <a href="https://www.psychologicalscience.org/publications/observer/obsonline/congress-stops-nih-from-implement-new-clinical-trials-policy.html">Click here</a> to read the full article. </span></p>
<p class="p1"><span class="s1">Psychological science is in the midst of a period of renewed focus on issues of replicability, rigor, and openness. What does this mean for psychophysiological research? Come join us in our discussion of this at the 2018 meeting of SPR (October 3-7 in Quebec City; submit your poster abstracts now through April 2</span><span class="s1">!). This session will feature a panel discussion of psychophysiologists engaged in diverse activities aimed at these broad goals. Two teams of SPR members (<strong>Team One</strong>: MacNamara, van Reekum, Morriss, Sandre, and Weinberg. <strong>Team Two</strong>: Larson, Moser, Umemoto, and Inzlicht) will discuss two ongoing cross-laboratory efforts at direct and conceptual replications of psychophysiology experiments. Andreas Keil and Emily Kappenman will discuss, among other things, the recent special issue of the journal (Re-centering Science: Reliability, Robustness, and Reproducibility in Psychophysiological Research); Michael Inzlicht will moderate (panel organized by Jesse Kaye and Anna Weinberg). The group will engage in conversation and questions with the membership of the Society to consider the tremendous challenges as well as opportunities that come with efforts to continue to build a stronger science.</span></p> <img class="alignnone wp-image-7351 size-full" src="http://www.sprweb.org/wp-content/uploads/2018/03/OpenScience.jpg" alt="" width="582" height="464" />